以板块分布统计，养老金账户持有个股中主板有9只、科创板有1只、创业板有2只。按行业统计，养老 金账户持股主要集中在机械设备、基础化工行业，分别有3只、2只个股上榜。 业绩方面，养老金账户现身个股中，半年报净利润实现增长的有11家，净利润增幅最高的是容知日新， 公司共实现净利润1423.55万元，同比增长2063.42%。（数据宝） 养老金持股明细 养老金二级市场上持续落子布局，二季度末共现身12只个股前十大流通股东榜，其中，新进7只，增持3 只。 证券时报 数据宝统计显示，养老金账户最新出现在12只个股前十大流通股东名单中，合计持股量0.89亿 股，期末持股市值合计35.11亿元。 二季度末养老金账户对宏发股份（600885）的持股量最多，基本养老保险基金八零七组合、基本养老保 险基金一五零二二组合为公司第九、第七大流通股东，合计持股量为2822.27万股；其次是卫星化学 （002648），基本养老保险基金八零八组合为公司第十大流通股东，持股量为1996.72万股。从期末持 股市值看，养老金账户期末持股市值在亿元以上的有7只股，分别是春风动力（603129）、宏发股份、 卫星化学等。 持股比例方面，养老金账户 ...

公司最新总资产周转率为0.34次。最新存货周转率为4.45次。 公司最新资产负债率为55.07%，较上季度资产负债率增加1.45个百分点。 公司最新毛利率为20.56%，较上季度毛利率减少1.12个百分点，较去年同期毛利率减少0.52个百分点。最新ROE为8.82%。 公司摊薄每股收益为0.81元。 2025年8月12日，卫星化学(002648.SZ)发布2025年中报。 公司营业总收入为234.60亿元。归母净利润为27.44亿元。经营活动现金净流入为50.52亿元。 公司股东户数为9.32万户，前十大股东持股数量为20.07亿股，占总股本比例为59.59%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 浙江卫星控股股份有限公司 | 34.61 | | 2 | YANG YA ZHEN | 11.6 | | 3 | 香港中央结算有限公司 | 4.46 | | 4 | 嘉兴茂源投资有限公司 | 4.15 | | 5 | 洪涛 | 1.32 | | 6 | 中国工商银行股份有限公司-华泰柏瑞沪深300交易型开放式指数证券投资基金 | 0.89 ...

对于社保基金，本期新披露持有卫星化学的社保基金共计1个，即全国社保基金一零一组合。 外资态度来看，本期较上一季度持股减少的外资基金共计1个，即香港中央结算有限公司，持股减少占 比达3.75%。本期较上一季度新披露的外资机构有 1 家 ，即GATES FOUNDATION TRUST。本期较上 一季未再披露的外资机构包括BILL & MELINDA GATES FOUNDATION TRUST、科威特政府投资局。 2025年8月12日，卫星化学(002648.SZ)发布2025年半年度报告。截至2025年8月11日，共有61个机构投 资者披露持有卫星化学A股股份，合计持股量达16.24亿股，占卫星化学总股本的48.20%。其中，前十 大机构投资者包括浙江卫星控股股份有限公司、香港中央结算有限公司、嘉兴茂源投资有限公司、中国 工商银行股份有限公司-华泰柏瑞沪深300交易型开放式指数证券投资基金、GATES FOUNDATION TRUST、中国建设银行股份有限公司-易方达沪深300交易型开放式指数发起式证券投资基金、全国社保 基金一零一组合、基本养老保险基金八零八组合、招商瑞阳混合A、财通资管价值成长混合A，前十 ...

| | 卫星化学股份有限公司 | 2025 年半年度报告摘要 | | --- | --- | --- | | 证券代码：002648 证券简称：卫星化学 | | 公告编号：2025- | | 036 | | | | 卫星化学股份有限公司 2025 年半年度报告摘要 | | | | 一、重要提示 | | | | 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 | | | | 资者应当到证监 | | | | 会指定媒体仔细阅读半年度报告全文。 | | | | 所有董事均已出席了审议本报告的董事会会议。 | | | | 非标准审计意见提示 | | | | □适用 ?不适用 | | | | 董事会审议的报告期利润分配预案或公积金转增股本预案 | | | | □适用 ?不适用 | | | | 公司计划不派发现金红利，不送红股，不以公积金转增股本。 | | | | 董事会决议通过的本报告期优先股利润分配预案 | | | | □适用 ?不适用 | | | | 二、公司基本情况 | | | | 股票简称 卫星化学 | 股票代码 | 002648 | | 股票上市交易所 深圳证券交易 ...

证券代码：002648 证券简称：卫星化学 公告编号：2025-033 卫星化学股份有限公司 第五届董事会第十一次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 卫星化学股份有限公司（以下简称"公司"）第五届董事会第十一次会议通 知于2025年8月1日以邮件方式送达公司全体董事。本次会议于2025年8月11日在 公司会议室以现场表决与通讯表决结合的方式召开，会议应出席的董事9人，实 际出席的董事9人。 本次会议由公司董事长杨卫东先生主持，公司监事和高级管理人员列席了会 议。本次会议的召开符合《中华人民共和国公司法》《中华人民共和国证券法》 等法律、行政法规、部门规章、规范性文件和《卫星化学股份有限公司章程》等 规定。 二、会议审议情况 公司董事会编制的公司 2025 年半年度报告及摘要的程序符合法律、行政法 规和中国证券监督管理委员会的相关规定，报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏。具体内容详见同日披露于巨潮资讯网 （www.cninfo.com.cn）的《2025 年半年度报告》 （公告编号：2 ...

证券代码：002648 证券简称：卫星化学 公告编号：2025-034 卫星化学股份有限公司 第五届监事会第八次会议决议的公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 监事会认为：董事会编制的公司 2025 年半年度报告及摘要的程序符合法律、 行政法规和中国证券监督管理委员会的相关规定，报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏。具体内容详见同日披露于巨潮资讯网 （www.cninfo.com.cn）的《2025 年半年度报告》 （公告编号：2025-035）和披露 于《证券时报》 《中国证券报》和巨潮资讯网（www.cninfo.com.cn）的《2025 年 半年度报告摘要》（公告编号：2025-036）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 卫星化学股份有限公司（以下简称"公司"）第五届监事会第八次会议通知 于2025年8月1日以书面方式送达公司全体监事。本次会议于2025年8月11日在公 司会议室以现场表决与通讯表决结合的方式召开，会议应出席的监事3人，实际 出席的监事3人。 本次会议 ...

Core Viewpoint - The company aims to become a world-class chemical new materials technology company, focusing on high-quality development in the C2 and C3 industrial chains, with continuous innovation in functional chemicals, polymer new materials, new energy materials, hydrogen energy, and comprehensive utilization of carbon dioxide [1]. Financial Performance - The company reported a revenue of 23.46 billion yuan for the current reporting period, representing a year-on-year increase of 20.93% compared to 19.40 billion yuan in the same period last year [4]. - The net profit attributable to shareholders reached 2.74 billion yuan, up 33.44% from 2.06 billion yuan in the previous year [4]. - The net profit after deducting non-recurring gains and losses was 2.90 billion yuan, reflecting a 29.61% increase from 2.23 billion yuan [4]. - The net cash flow from operating activities was 5.05 billion yuan, a significant increase of 138.88% from 2.12 billion yuan [4]. - Basic and diluted earnings per share were both 0.81 yuan, marking a 32.79% increase from 0.61 yuan [4]. - The weighted average return on equity was 8.61%, up 0.80% from 7.81% [4]. C2 Sector Development - The company has established a comprehensive development matrix for downstream chemicals of ethylene oxide, with production capacities of 1.82 million tons of ethylene glycol, 500,000 tons of polyether monomers and surfactants, 200,000 tons of ethanolamine, and 150,000 tons of carbonates [2]. - The market share of ethanolamine and polyether monomers has steadily increased, with actual production ranking first and second nationally, respectively, both exceeding 20% market share [2]. - The company’s polyethylene and polystyrene products are tailored to market demands, with polyethylene recognized as an industry benchmark for stability and low impurity content, while polystyrene has improved toughness and high-temperature resistance, entering the core supply chain of major home appliance clients [2]. C3 Sector Development - The company has built the largest domestic and second-largest global production capacity for acrylic acid and esters [3]. - The new materials and new energy integrated project at the Pinghu base, with an annual production capacity of 800,000 tons of multi-carbon alcohol, successfully commenced operations, creating a closed-loop industrial chain with acrylic acid [3]. - The company has established the Satellite Global Company to accelerate overseas market expansion, with exports of acrylic acid and esters, polyether monomers, ethanolamine, and superabsorbent resins ranking among the top in China, collaborating with over 160 countries and regions [3].

Group 1 - Wanhua Chemical reported a 25.10% decrease in net profit for the first half of 2025, with revenue of 90.90 billion yuan, down 6.35% year-on-year [1][2] - The company's net profit attributable to shareholders was 6.12 billion yuan, while the net profit excluding non-recurring items was 6.24 billion yuan, both showing significant declines [1][2] - Despite challenges such as weak international demand and geopolitical tensions, the chemical industry in China maintained stable development due to domestic consumption upgrades and diversified export markets [2] Group 2 - Satellite Chemical achieved a 33.44% increase in net profit for the first half of 2025, with total assets reaching 69.30 billion yuan, up 5.58% year-on-year [4][5] - The company reported revenue of 23.46 billion yuan, a 20.93% increase compared to the previous year, demonstrating resilience in a complex environment [4][5] - The company is focusing on technological innovation and plans to invest 3 billion yuan in high-performance catalyst projects [5] Group 3 - Shengnong Development reported a 22.02% increase in sales revenue for July 2025, reaching 2.13 billion yuan, with significant growth in both poultry and processed meat segments [6][7] - The company noted a strong performance in high-value channels, with retail channel revenue growing over 30% year-on-year [7] Group 4 - Desay SV reported a 45.82% increase in net profit for the first half of 2025, with revenue of 14.64 billion yuan, up 25.25% year-on-year [8] - The smart cockpit and smart driving businesses contributed significantly to the revenue growth, with sales of 9.46 billion yuan and 4.15 billion yuan respectively [8] Group 5 - New Qianglian reported a remarkable 496.60% increase in net profit for the first half of 2025, with revenue of 2.21 billion yuan, up 108.98% year-on-year [16] - The company demonstrated strong growth in its financial performance, indicating effective operational strategies [16] Group 6 - Fuda Co. reported a 98.77% increase in net profit for the first half of 2025, with revenue of 937 million yuan, up 30.26% year-on-year [18] - The company showed significant growth in net profit excluding non-recurring items, indicating strong operational performance [18] Group 7 - Tianzhun Technology reported a revenue increase of 10.32% for the first half of 2025, reaching 597 million yuan, but still recorded a net loss of 14 million yuan [19] - The company’s total assets grew by 9.99% year-to-date, indicating a positive trend in asset management [19] Group 8 - Huafeng Chemical reported a 35.23% decrease in net profit for the first half of 2025, with revenue of 12.14 billion yuan, down 11.7% year-on-year due to industry downturns [28] - The company faced challenges with declining product prices across various segments, impacting overall profitability [28] Group 9 - The company Zhishang Technology plans to acquire 99.86% of Hengyang Data for 1.15 billion yuan, focusing on AI and cloud computing solutions [29] - This acquisition aims to enhance the company's capabilities in intelligent computing and data processing [29] Group 10 - Huangshanghuang plans to acquire 51% of Lixing Food for 495 million yuan, which will allow it to gain control over the food manufacturing company [30] - This acquisition is part of the company's strategy to expand its product offerings and market presence [30] Group 11 - Beida Pharmaceutical faces significant revenue and profit declines due to the termination of its business cooperation with Peking University International Hospital, projecting a loss of approximately 600 million yuan in sales [31] - The company is exploring new directions for transformation, but faces uncertainty regarding its future operations [31]

2025年上半年，卫星化学坚持「守正创新」工作主线，纵深推进「两个领先」战略部署，围绕高端材料 布局与核心技术突破，强化组织协同与创新转化能力，推动「创新力」加速转化为「竞争力」，夯实未 来增长动能，走好高质量发展的技术突围之路。公司加快构建未来研发中心，聚焦催化剂、新能源材 料、高分子新材料、功能化学品等关键领域，加快原创技术研发及产业化进程。 报告期内，公司研发投入7.73亿元，申请专利122件、授权57件，高性能催化新材料项目正式落地，计 划投资30亿元，打造一体化产研平台。 产业链协同提质，产品力支撑竞争优势 围绕「补链、延链、强链」持续发力，公司系统推进乙烷、丙烷两大原料路线下游的高效协同，加快各 基地重点项目建设，着力提升研产销一体化能力。公司以功能化学品为核心，优化产品结构、完善配套 矩阵，着力打造集原料调控、精益制造、渠道渗透于一体的全链条竞争力。围绕关键节点，公司不断提 升产品性能、拓展高端应用场景，推动多基地协同发展与资源高效配置，显著增强一体化抗风险能力与 盈利能力。 2025年8月11日晚间，轻烃行业龙头卫星化学(002648)发布2025年半年度报告。报告显示2025年1月至6 月， ...

证券日报网讯 8月11日晚间，卫星化学发布公告称，公司第五届监事会第八次会议审议通过了《关于 2025年半年度报告及摘要的议案》。 （文章来源：证券日报） ...